Assessment of Coronary Artery Disease Before Transcatheter Aortic Valve Replacement: A Randomized, Multicenter, Non-Inferiority Trial

NARecruitingINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

August 14, 2025

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Aortic Valve Stenosis and InsufficiencyCoronary Artery Disease(CAD)Transcatheter Aortic Valve Replacement (TAVR)
Interventions
DIAGNOSTIC_TEST

Standard Invasive Coronary Angiography

Standard invasive coronary angiography performed routinely for all participants in this arm to assess coronary artery disease before TAVR.

DIAGNOSTIC_TEST

PCD-CT-Guided Diagnostic Strategy

Participants randomized to this arm will undergo coronary artery disease (CAD) assessment using photon-counting detector computed tomography (PCD-CT). Invasive coronary angiography (ICA) will only be performed if PCD-CT shows significant CAD, defined as ≥70% diameter stenosis in vessels ≥2.5 mm or ≥50% in the left main artery.

Trial Locations (1)

6020

RECRUITING

Medical University of Innsbruck, Innsbruck

All Listed Sponsors
lead

Medical University Innsbruck

OTHER

NCT07107568 - Assessment of Coronary Artery Disease Before Transcatheter Aortic Valve Replacement: A Randomized, Multicenter, Non-Inferiority Trial | Biotech Hunter | Biotech Hunter